Influence of Bladder Contractility on Short-Term Outcomes of High-Power Potassium-Titanyl-Phosphate Photoselective Vaporization of the Prostate

Urology

Volumn 69, Issue 5, 2007, Pages 859-863

  Paick, Jae Seung ^a   Um, Jin Mo ^a   Kwak, Cheol ^a   Kim, Soo Woong ^a   Ku, Ja Hyeon ^b  

^a Seoul National University Hospital   (South Korea)

^b Seoul Veterans Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE; POTASSIUM; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CONTRACTION; BLADDER OBSTRUCTION; CONTROLLED STUDY; FOLLOW UP; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RESIDUAL URINE; SCORING SYSTEM; UROFLOWMETRY; VAPORIZATION;

AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PATIENT SATISFACTION; PHOSPHATES; PROBABILITY; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TITANIUM; TREATMENT OUTCOME; URINARY BLADDER; URINARY RETENTION; URODYNAMICS; VOLATILIZATION;

EID: 34247581738     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.01.042     Document Type: Article

References (30)

1. Hai M.A., and Malek R.S. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 17 (2003) 93-96
2. Te A.E., Malloy T.R., Stein B.S., et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 72 (2004) 1404-1408
3. Sandhu J.S., Ng C., Vanderbrink B.A., et al. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 64 (2004) 1155-1159
4. Sandhu J.S., Ng C.K., Gonzalez R.R., et al. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 19 (2005) 1196-1198
5. Sulser T., Reich O., Wyler S., et al. Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures. J Endourol 18 (2004) 976-981
6. Reich O., Bachmann A., Siebels M., et al. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173 (2005) 158-160
7. Kumar S.M. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. J Urol 173 (2005) 511-513
8. Malek R.S., Kuntzman R.S., and Barrett D.M. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 174 (2005) 1344-1348
9. Bachmann A., Ruszat R., Wyler S., et al. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol 47 (2005) 798-804
10. Volkan T., Ihsan T.A., Yilmaz O., et al. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol 48 (2005) 608-613
11. Sarica K., Alkan E., Luleci H., et al. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol 19 (2005) 1199-1202
12. Barber N.J., Zhu G., Donohue J.F., et al. Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate. Urology 67 (2006) 80-83
13. van Venrooij G.E., Boon T.A., and de Gier R.P.E. International Prostate Symptom Score and quality of life assessment versus urodynamic parameters in males with benign prostatic hyperplasia symptoms. J Urol 153 (1995) 1516-1519
14. Gotoh M., Yoshikawa Y., Kondo A.S., et al. Prognostic value of pressure-flow study in surgical treatment of benign prostatic obstruction. World J Urol 17 (1999) 274-278
15. Abrams P., Cardozo L., Fall M., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 21 (2002) 167-178
16. Abrams P.H., and Griffiths D.J. The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol 51 (1997) 129-134
17. Lim C.S., and Abrams P. The Abrams-Griffiths nomogram. World J Urol 13 (1995) 34-39
18. Schafer W. Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol 13 (1995) 47-58
19. Shingleton W.B., Terrell F., Renfroe D.L., et al. A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 54 (1999) 1017-1021
20. Shingleton W.B., Renfroe L.D., Kolski J.M., et al. A randomized prospective study of transurethral electrovaporization vs laser ablation of the prostate in men with benign prostatic hypertrophy. Scand J Urol Nephrol 32 (1998) 266-269
21. Kuntzman R.S., Malek R.S., Barrett D.M., et al. Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology 48 (1996) 575-583
22. Kuntzman R.S., Malek R.S., Barrett D.M., et al. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 49 (1997) 703-708
23. Levin R.M., Monson F.C., Haugaard N., et al. Genetic and cellular characteristics of bladder outlet obstruction. Urol Clin North Am 22 (1995) 263-283
24. van Venrooij G.E., van Melick H.H.E., Eckhardt M.D., et al. Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate. J Urol 168 (2002) 605-609
25. Shapiro E., and Lepor H. Pathophysiology of clinical benign prostatic hyperplasia. Urol Clin North Am 22 (1995) 285-290
26. Andersson K.E. Storage and voiding symptoms: pathophysiological aspects. Urology 62 suppl 5B (2003) 3-10
27. Thomas A.W., Cannon A., Bartlett E., et al. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int 93 (2004) 745-750
28. Neal D.E., Ramsden P.D., Sharples L., et al. Outcome of elective prostatectomy. BMJ 299 (1989) 762-767
29. Al-Hayek S., Thomas A., and Abrams P. Natural history of detrusor contractility-minimum ten-year urodynamic follow-up in men with bladder outlet obstruction and those with detrusor. Scand J Urol Nephrol Suppl 215 (2004) 101-108
30. Guess H.A., Chute C.G., Garraway W.M., et al. Similar levels of urological symptoms have similar impact on Scottish and American men-although Scots report less symptoms. J Urol 150 (1993) 1701-1705